PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 70 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $92 | -99.9% | 15,307 | -3.5% | 0.00% | – |
| Q3 2022 | $104,000 | +20.9% | 15,867 | -4.5% | 0.00% | – |
| Q2 2022 | $86,000 | -39.0% | 16,617 | -18.8% | 0.00% | – |
| Q1 2022 | $141,000 | -50.4% | 20,467 | -10.4% | 0.00% | -100.0% |
| Q4 2021 | $284,000 | -32.5% | 22,832 | +69.4% | 0.00% | 0.0% |
| Q3 2021 | $421,000 | +34.9% | 13,482 | +23.4% | 0.00% | 0.0% |
| Q2 2021 | $312,000 | – | 10,927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |